EP3103796B1 - Novel compound and epoxy resin composition containing same - Google Patents

Novel compound and epoxy resin composition containing same Download PDF

Info

Publication number
EP3103796B1
EP3103796B1 EP15745854.8A EP15745854A EP3103796B1 EP 3103796 B1 EP3103796 B1 EP 3103796B1 EP 15745854 A EP15745854 A EP 15745854A EP 3103796 B1 EP3103796 B1 EP 3103796B1
Authority
EP
European Patent Office
Prior art keywords
epoxy resin
resin composition
acid
pack type
curing agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP15745854.8A
Other languages
German (de)
French (fr)
Other versions
EP3103796A1 (en
EP3103796A4 (en
Inventor
Takeshi Endo
Kozo Matsumoto
Daisuke Sato
Ryo Ogawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adeka Corp
Original Assignee
Adeka Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2014021055A external-priority patent/JP6240940B2/en
Priority claimed from JP2014076349A external-priority patent/JP6300608B2/en
Application filed by Adeka Corp filed Critical Adeka Corp
Publication of EP3103796A1 publication Critical patent/EP3103796A1/en
Publication of EP3103796A4 publication Critical patent/EP3103796A4/en
Application granted granted Critical
Publication of EP3103796B1 publication Critical patent/EP3103796B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G59/00Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
    • C08G59/18Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
    • C08G59/40Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the curing agents used
    • C08G59/50Amines
    • C08G59/5046Amines heterocyclic
    • C08G59/5053Amines heterocyclic containing only nitrogen as a heteroatom
    • C08G59/5073Amines heterocyclic containing only nitrogen as a heteroatom having two nitrogen atoms in the ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/58Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08Radicals containing only hydrogen and carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G59/00Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
    • C08G59/18Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
    • C08G59/40Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the curing agents used
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L63/00Compositions of epoxy resins; Compositions of derivatives of epoxy resins

Definitions

  • This invention relates to an epoxy resin composition containing a specific dicyanamide salt and a one-pack type thermosetting epoxy resin composition containing the salt and having excellent storage stability and curability.
  • Epoxy resins exhibit high adhesion to various substrates. Cured products of epoxy resins have relatively excellent properties, such as heat resistance, chemical resistance, electric characteristics, and mechanical characteristics, and are useful in a wide range of applications, including coatings, adhesives, and molding materials.
  • a two-pack type epoxy resin composition is characterized by curability at ambient or low temperature. Nevertheless, a two-pack epoxy resin composition is disadvantageous in that the two packs must be metered and mixed immediately before use and that the pot life of the composition is short and therefore has a limited use, for example, meeting difficulty in applying to automatic machinery. To eliminate these disadvantages, a one-pack type epoxy resin composition has been demanded.
  • Latent curing agents so far proposed include dicyandiamide, dibasic acid hydrazides, amine-boron trifluoride complex salts, guanamines, melamine, and imidazoles. They have, however, their own disadvantages. That is, mixtures of en epoxy resin with dicyandiamide, melamine, or guanamines are, while excellent in storage stability, problematic in that they need a high temperature (150°C or higher) and a long time to cure.
  • compositions containing a dibasic acid dihydrazide or an imidazole cure at relatively low temperatures but have poor storage stability.
  • compositions containing an amine-boron trifluoride complex salt have high storage stability and cure in short times, they are poor in water resistance and corrosive to metals.
  • Patent Document 1 proposes using an ionic liquid composed of, e.g., a combination of an ammonium- or phosphonium-based cation and a carboxylate anion as an epoxy resin curing agent. The results are still unsatisfactory.
  • Patent Document 1 US 2009/0030158 US 4,761,466 discloses an adhesive composition comprising a mixture of a polyepoxide, an amine curing agent and a particular thiocyanate salt.
  • WO 2012/042673 A1 discloses a two-pack curable epoxy resin coating composition for a floor member containing, in relation to 100 parts by mass of an epoxy resin (component (a)), 10 to 75 parts by mass of a vinyl monomer and/or a (meth)acrylate monomer (component (b)), 0 to 50 parts by mass of a denaturant (component (c)), 0 to 50 parts by mass of an epoxy (meth)acrylate (component (d)), and 15 to 45 parts by mass of a curing agent (component (e)); and 0.5 to 10 parts by mass of an ionic liquid (component (f)) in relation to 100 parts by mass of the sum of components (a) to (e).
  • An object of the invention is to provide an epoxy resin composition excellent in storage stability and curability.
  • the invention provides an epoxy resin composition containing (A) an epoxy resin and (B) at least one of compounds represented by general formulae (1-1), (1-3), (1-4) or (1-5): wherein R2', R3, R4, R5, R9, R10, R11, R12, R13, R14, and R15 each independently represent a hydrogen atom, an alkyl group, or an aryl group; and X represents a dicyanamide ion.
  • the invention provides a practically useful epoxy resin composition that is composed of easily available components and exhibits moderate curing characteristics and storage stability in good balance.
  • the invention provides a one-pack type epoxy resin composition free from a curing resin component that is solid at ambient temperature, so that the resin composition has excellent workability and is suitable for application to tight, hard-to-reach places or impregnation application.
  • Examples of the alkyl group as represented by R2', R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, and R15 in general formulae (1-1) through (I-5) include those having 1 to 10 carbon atoms, such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, t-butyl, amyl, isoamyl, t-amyl, hexyl, isohexyl, octyl, 2-ethylhexyl, t-octyl, nonyl, and decyl.
  • Examples of the aryl group as represented by R2', R3, R4, R5, R6, R7, R8, R9, RIO, R11, R12, R13, R14, and R15 include those having 6 to 12 carbon atoms, such as phenyl and naphthyl.
  • the compound having general formula (I) in which X is a dicyanamide ion can be prepared by adding an acidic substance, such as hydrochloric acid, to a nitrogen-containing heterocyclic compound corresponding to a desired cation structure to form an intermediate (1-1), which is then caused to react with sodium dicyandiamide or a dicyandiamide salt in the presence of an alcohol or water as shown in the following reaction scheme: wherein R1 represents the partial cyclic structure of compounds represented by the above-mentioned general formulae (1-1), (1-3), (1-4) and (1-5); and R2, and R3 are the same groups as R2' and R3 in the above-mentioned general formulae (1-1), (1-3), (1-4) and (1-5).
  • an acidic substance such as hydrochloric acid
  • Examples of the epoxy resin that can be used in the epoxy resin composition of the invention as component (A) include polyglycidyl ethers of mononuclear polyhydric phenol compounds, such as hydroquinone, resorcin, pyrocatechol, and phloroglucinol; polyglycidyl ethers of polynuclear polyhydric phenol compounds, such as dihydroxynaphthalene, biphenol, methylenebisphenol (i.e., bisphenol F), methylenebis(ortho-cresol), ethylidenebisphenol, isopropylidenebisphenol (i.e., bisphenol A), isopropylidenebis(ortho-cresol), tetrabromobisphenol A, 1,3 -bis(4-hydroxycumylbenzene), 1,4-bis(4-hydroxycumylbenzene), 1,1,3-tris(4-hydroxyphenyl)butane, 1,1,2,2-tetra(4-hydroxyphen
  • polyepoxy compounds may be internally crosslinked by an isocyanate-terminated prepolymer or may have their molecular weight increased using a polyfunctional polyhydric active hydrogen compound, e.g., a polyhydric phenol, a polyamine, a carbonyl-containing compound, or a polyphosphoric ester.
  • a polyfunctional polyhydric active hydrogen compound e.g., a polyhydric phenol, a polyamine, a carbonyl-containing compound, or a polyphosphoric ester.
  • Preferred of the recited epoxy resins (A) are polyglycidyl ethers of polynuclear polyhydric phenol compounds in terms of workability and curability, with bisphenol F and bisphenol A being more preferred.
  • the epoxy resin (A) preferably has an epoxy equivalent of from 70 to 3,000, more preferably 90 to 2,000. With an epoxy equivalent less than 70, the physical properties of the cured product can reduce. With an epoxy equivalent larger than 3,000, curability can be insufficient.
  • Component (B) that can be used in the epoxy resin composition of the invention is at least one of the compounds represented by general formulae (I-1), (1-3), (1-4) and (1-5), the examples of which have been described.
  • the amount of the compound (B) of formula (I) used in the epoxy resin composition of the invention is preferably 0.1 to 50 parts, more preferably 1 to 20 parts, by mass per 100 parts by mass of the epoxy resin (A). If the content of compound (B) is less than 0.1 parts, insufficient cure can result. If it exceeds 50 parts, the storage stability of the epoxy resin composition can be impaired considerably.
  • the epoxy resin composition may contain commonly used additives, including other curing agents except the compound (B) of at least one of formulae (I-1), (1-3), (1-4) and (1-5); curing catalysts; reactive or nonreactive diluents (plasticizers), such as monoglycidyl ethers, dioctyl phthalate, dibutyl phthalate, benzyl alcohol, and coal tar; fillers or pigments, such as glass fiber, carbon fiber, cellulose, silica sand, cement, kaolin, clay, aluminum hydroxide, bentonite, talc, silica, finely divided silica, titanium dioxide, carbon black, graphite, iron oxide, and bituminous materials; silane coupling agents, such as ⁇ -aminopropyltriethoxysilane, N- ⁇ -(aminoethyl)- ⁇ -aminopropyltriethoxysilane, N- ⁇ -(aminoethyl)-N
  • the epoxy resin composition of the invention can be used for a wide range of applications, such as coatings or adhesives for concrete, cement mortar, various metals, leather, glass, rubber, plastics, wood, cloth, and paper; pressure-sensitive adhesives for packaging adhesive tape, adhesive labels, labels for frozen foods, removable labels, labels for POS system, adhesive wallpaper, and adhesive flooring; processed paper, such as art paper, light-weight coated paper, cast-coated paper, coated paperboard, carbonless copy paper, and impregnated paper; textile processing agents, such as sizing agents, anti-fray agents, and processing agents for natural fibers, synthetic fibers, glass fiber, carbon fiber, and metal fibers; building materials, such as sealants, cement admixtures, and waterproof materials; and sealants for electronic/electric devices.
  • applications such as coatings or adhesives for concrete, cement mortar, various metals, leather, glass, rubber, plastics, wood, cloth, and paper; pressure-sensitive adhesives for packaging adhesive tape, adhesive labels, labels for frozen foods, removable labels, labels for POS system, adhesive wallpaper,
  • One-pack type epoxy resin composition A-1 was prepared by uniformly mixing 340 g of Adeka Resin EP-4100L from Adeka Corp. (bisphenol A diglycidyl ether epoxy resin; epoxy equivalent: 170 g/eq.; total chlorine content: 600 ppm) with 15 g of curing agent A-1, followed by thoroughly defoaming under reduced pressure at room temperature.
  • Adeka Resin EP-4100L bisphenol A diglycidyl ether epoxy resin; epoxy equivalent: 170 g/eq.; total chlorine content: 600 ppm
  • One-pack type epoxy resin composition B-1 was prepared in the same manner as in Example 4, except for using 17.7 g of curing agent B-1.
  • One-pack type epoxy resin composition C-1 was prepared in the same manner as in Example 4-1, except for using 16.5 g of curing agent C-1.
  • One-pack type epoxy resin composition D was prepared in the same manner as in Example 4-1, except for using 8.2 g of 1-methylimidazole.
  • One-pack type epoxy resin composition E was prepared in the same manner as in Example 4-1, except for using 11 g of 2-ethyl-4-methylimidazole.
  • One-pack type epoxy resin composition D was prepared in the same manner as in Example 4-1, except for using 9.8 g of 1-methyl-1,4,5,6-tetrahydropyrimidine.
  • the one-pack type epoxy resin compositions obtained in Examples and Comparative Examples were evaluated for physical properties in accordance with the following methods.
  • the one-pack type epoxy resin composition was stored hermetically at 40°C immediately after the preparation. The time required for the composition to lose flowability was recorded as a measure for evaluating one-pack stability.
  • the one-pack type epoxy resin composition was caused to gel on a hot plate at 150°C and 180°C. The gelling time was recorded to evaluate curability.
  • Example 4-1 Comp.
  • Example 1 Example 5-1 Comp.
  • Example 2 Example 6-1 Comp.
  • Example 3 One-pack Stability (hr) 48 12 48 6 >200 72 Gel Time (min) 150°C 1'45" 1'55" 1'10" 1'12" >60 >60 180°C 0'45" 0'48" 0'30" 0'30" 35 >60
  • the use of the nitrogen-containing salt compound having a dicyanamide anion structure as a thermosetting type latent curing agent for epoxy resins provides a one-pack type epoxy resin composition excellent in not only one-pack stability but curability.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Epoxy Resins (AREA)

Description

    TECHNICAL FIELD
  • This invention relates to an epoxy resin composition containing a specific dicyanamide salt and a one-pack type thermosetting epoxy resin composition containing the salt and having excellent storage stability and curability.
  • BACKGROUND ART
  • Epoxy resins exhibit high adhesion to various substrates. Cured products of epoxy resins have relatively excellent properties, such as heat resistance, chemical resistance, electric characteristics, and mechanical characteristics, and are useful in a wide range of applications, including coatings, adhesives, and molding materials.
  • Conventional epoxy resin compositions are mostly of two-pack type in which an epoxy resin component is mixed with a curing agent or a curing accelerator on use. A two-pack type epoxy resin composition is characterized by curability at ambient or low temperature. Nevertheless, a two-pack epoxy resin composition is disadvantageous in that the two packs must be metered and mixed immediately before use and that the pot life of the composition is short and therefore has a limited use, for example, meeting difficulty in applying to automatic machinery. To eliminate these disadvantages, a one-pack type epoxy resin composition has been demanded.
  • In order to develop a one-pack type curing resin composition, a curing agent that does not react at room temperature but commences reaction to cure upon heating, i.e., a latent curing agent is necessary. Latent curing agents so far proposed include dicyandiamide, dibasic acid hydrazides, amine-boron trifluoride complex salts, guanamines, melamine, and imidazoles. They have, however, their own disadvantages. That is, mixtures of en epoxy resin with dicyandiamide, melamine, or guanamines are, while excellent in storage stability, problematic in that they need a high temperature (150°C or higher) and a long time to cure. It is widely practiced to use a curing accelerator in combination to shorten the curing time, but this is accompanied by remarkable reduction in storage stability. On the other hand, compositions containing a dibasic acid dihydrazide or an imidazole cure at relatively low temperatures but have poor storage stability. While compositions containing an amine-boron trifluoride complex salt have high storage stability and cure in short times, they are poor in water resistance and corrosive to metals.
  • Patent Document 1 below proposes using an ionic liquid composed of, e.g., a combination of an ammonium- or phosphonium-based cation and a carboxylate anion as an epoxy resin curing agent. The results are still unsatisfactory.
  • CITATION LIST Patent Document
  • Patent Document 1: US 2009/0030158
    US 4,761,466 discloses an adhesive composition comprising a mixture of a polyepoxide, an amine curing agent and a particular thiocyanate salt.
    WO 2012/042673 A1 discloses a two-pack curable epoxy resin coating composition for a floor member containing, in relation to 100 parts by mass of an epoxy resin (component (a)), 10 to 75 parts by mass of a vinyl monomer and/or a (meth)acrylate monomer (component (b)), 0 to 50 parts by mass of a denaturant (component (c)), 0 to 50 parts by mass of an epoxy (meth)acrylate (component (d)), and 15 to 45 parts by mass of a curing agent (component (e)); and 0.5 to 10 parts by mass of an ionic liquid (component (f)) in relation to 100 parts by mass of the sum of components (a) to (e).
  • SUMMARY OF THE INVENTION Problem to be Solved by the Invention:
  • An object of the invention is to provide an epoxy resin composition excellent in storage stability and curability.
  • Means for Solving the Problem:
  • As a result of extensive investigations with a view to accomplishing the above object, the inventors have found a specific dicyanamide salt exhibits excellent effects as an epoxy resin curing agent and achieved the object of the invention. The invention has been completed based on this finding.
  • The invention provides an epoxy resin composition containing (A) an epoxy resin and (B) at least one of compounds represented by general formulae (1-1), (1-3), (1-4) or (1-5):
    Figure imgb0001
    Figure imgb0002
    wherein R2', R3, R4, R5, R9, R10, R11, R12, R13, R14, and R15 each independently represent a hydrogen atom, an alkyl group, or an aryl group; and X represents a dicyanamide ion.
  • Effect of the Invention:
  • The invention provides a practically useful epoxy resin composition that is composed of easily available components and exhibits moderate curing characteristics and storage stability in good balance. In particular, the invention provides a one-pack type epoxy resin composition free from a curing resin component that is solid at ambient temperature, so that the resin composition has excellent workability and is suitable for application to tight, hard-to-reach places or impregnation application.
  • BRIEF DESCRIPTION OF THE DRAWINGS
    • Fig. 1 is a 1H-NMR spectrum of curing agent B-1 (compound No. 2-1) prepared in Example 2-1.
    • Fig. 2 is a 13C-NMR spectrum of curing agent B-1 (compound No. 2-1) prepared in Example 2-1.
    EMBODIMENTS FOR CARRYING OUT THE INVENTION
  • The invention will be described in detail with reference to its preferred embodiments.
  • Examples of the alkyl group as represented by R2', R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, and R15 in general formulae (1-1) through (I-5) include those having 1 to 10 carbon atoms, such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, t-butyl, amyl, isoamyl, t-amyl, hexyl, isohexyl, octyl, 2-ethylhexyl, t-octyl, nonyl, and decyl. Examples of the aryl group as represented by R2', R3, R4, R5, R6, R7, R8, R9, RIO, R11, R12, R13, R14, and R15 include those having 6 to 12 carbon atoms, such as phenyl and naphthyl.
  • Specific examples of the compound of general formula (I) in which X is a dicyanamide ion include, but are not limited to, compound Nos. 1-1 to 5-1 shown below.
    Figure imgb0003
    Figure imgb0004
    Figure imgb0005
    Figure imgb0006
    Figure imgb0007
    Figure imgb0008
  • While not being limited, the compound having general formula (I) in which X is a dicyanamide ion can be prepared by adding an acidic substance, such as hydrochloric acid, to a nitrogen-containing heterocyclic compound corresponding to a desired cation structure to form an intermediate (1-1), which is then caused to react with sodium dicyandiamide or a dicyandiamide salt in the presence of an alcohol or water as shown in the following reaction scheme:
    Figure imgb0009
    wherein R1 represents the partial cyclic structure of compounds represented by the above-mentioned general formulae (1-1), (1-3), (1-4) and (1-5); and R2, and R3 are the same groups as R2' and R3 in the above-mentioned general formulae (1-1), (1-3), (1-4) and (1-5).
  • The epoxy resin composition of the invention will next be described.
  • Examples of the epoxy resin that can be used in the epoxy resin composition of the invention as component (A) include polyglycidyl ethers of mononuclear polyhydric phenol compounds, such as hydroquinone, resorcin, pyrocatechol, and phloroglucinol; polyglycidyl ethers of polynuclear polyhydric phenol compounds, such as dihydroxynaphthalene, biphenol, methylenebisphenol (i.e., bisphenol F), methylenebis(ortho-cresol), ethylidenebisphenol, isopropylidenebisphenol (i.e., bisphenol A), isopropylidenebis(ortho-cresol), tetrabromobisphenol A, 1,3 -bis(4-hydroxycumylbenzene), 1,4-bis(4-hydroxycumylbenzene), 1,1,3-tris(4-hydroxyphenyl)butane, 1,1,2,2-tetra(4-hydroxyphenyl)ethane, thiobisphenol, sulfobisphenol, oxybisphenol, phenol novolak, ortho-cresol novolak, ethylphenol novolak, butylphenol novolak, octylphenol novolak, resorcin novolak, and terpenediphenol; polyglycidyl ethers of polyhydric alcohols, such as ethylene glycol, propylene glycol, butylene glycol, hexanediol, polyglycol, thiodiglycol, glycerol, trimethylolpropane, pentaerythritol, sorbitol, and bisphenol A ethylene oxide adducts; homo- or copolymers of glycidyl esters of aliphatic, aromatic or alicyclic polybasic acids, such as maleic acid, fumaric acid, itaconic acid, succinic acid, glutaric acid, suberic acid, adipic acid, azelaic acid, sebacic acid, dimer acid, trimer acid, phthalic acid, isophthalic acid, terephthalic acid, trimellitic acid, trimesic acid, pyromellitic acid, tetrahydrophthalic acid, hexahydrophthalic acid, and endomethylenetetrahydrophthalic acid, and glycidyl methacrylate; epoxy compounds having a glycidylamino group, such as N,N-diglycidylaniline, bis(4-(N-methyl-N-glycidylamino)phenyl)methane, and diglycidyl o-toluidine; epoxidized cyclic olefin compounds, such as vinylcyclohexene diepoxide, dicyclopentanediene diepoxide, 3,4-epoxycyclohexylmethyl 3,4-epoxycyclohexanecarboxylate, 3,4-epoxy-6-methylcyclohexylmethyl 6-methylcyclohexanecarboxylate, and bis(3,4-epoxy-6-methylcyclohexylmethyl) adipate; epoxidized conjugated diene polymers, such as epoxidized polybutadiene and epoxidized styrene-butadiene copolymers; and heterocyclic compounds, such as triglycidyl isocyanurate. These polyepoxy compounds may be internally crosslinked by an isocyanate-terminated prepolymer or may have their molecular weight increased using a polyfunctional polyhydric active hydrogen compound, e.g., a polyhydric phenol, a polyamine, a carbonyl-containing compound, or a polyphosphoric ester.
  • Preferred of the recited epoxy resins (A) are polyglycidyl ethers of polynuclear polyhydric phenol compounds in terms of workability and curability, with bisphenol F and bisphenol A being more preferred.
  • The epoxy resin (A) preferably has an epoxy equivalent of from 70 to 3,000, more preferably 90 to 2,000. With an epoxy equivalent less than 70, the physical properties of the cured product can reduce. With an epoxy equivalent larger than 3,000, curability can be insufficient.
  • Component (B) that can be used in the epoxy resin composition of the invention is at least one of the compounds represented by general formulae (I-1), (1-3), (1-4) and (1-5), the examples of which have been described.
  • The amount of the compound (B) of formula (I) used in the epoxy resin composition of the invention is preferably 0.1 to 50 parts, more preferably 1 to 20 parts, by mass per 100 parts by mass of the epoxy resin (A). If the content of compound (B) is less than 0.1 parts, insufficient cure can result. If it exceeds 50 parts, the storage stability of the epoxy resin composition can be impaired considerably.
  • If necessary, the epoxy resin composition may contain commonly used additives, including other curing agents except the compound (B) of at least one of formulae (I-1), (1-3), (1-4) and (1-5); curing catalysts; reactive or nonreactive diluents (plasticizers), such as monoglycidyl ethers, dioctyl phthalate, dibutyl phthalate, benzyl alcohol, and coal tar; fillers or pigments, such as glass fiber, carbon fiber, cellulose, silica sand, cement, kaolin, clay, aluminum hydroxide, bentonite, talc, silica, finely divided silica, titanium dioxide, carbon black, graphite, iron oxide, and bituminous materials; silane coupling agents, such as γ-aminopropyltriethoxysilane, N-β-(aminoethyl)-γ-aminopropyltriethoxysilane, N-β-(aminoethyl)-N'-β-(aminoethyl)-γ-aminopropyltriethoxysilane, γ-anilinopropyltriethoxysilane, γ-glycidoxypropyltriethoxysilane, β-(3,4-epoxycyclohexyl)ethyltriethoxysilane, vinyl triethoxysilane, N-β-(N-vinylbenzylaminoethyl)-γ-aminopropyltriethoxysilane, γ-methacryloxypropyltrimethoxysilane, γ-chloropropyltrimethoxy silane, and γ-mercaptopropyltrimethoxysilane; lubricants, such as candelilla wax, carnauba wax, Japan wax, insect wax, beeswax, lanolin, spermaceti wax, montan wax, petroleum wax, fatty acid waxes, fatty acid esters, fatty acid ethers, aromatic esters, and aromatic ethers; thickeners; thixotropic agents; antioxidants; light stabilizers; UV absorbers; flame retardants; defoamers; rust inhibitors; colloidal silica, and colloidal alumina. Adhesive resins, such as xylene resin and petroleum resins, may be used in combination.
  • The epoxy resin composition of the invention can be used for a wide range of applications, such as coatings or adhesives for concrete, cement mortar, various metals, leather, glass, rubber, plastics, wood, cloth, and paper; pressure-sensitive adhesives for packaging adhesive tape, adhesive labels, labels for frozen foods, removable labels, labels for POS system, adhesive wallpaper, and adhesive flooring; processed paper, such as art paper, light-weight coated paper, cast-coated paper, coated paperboard, carbonless copy paper, and impregnated paper; textile processing agents, such as sizing agents, anti-fray agents, and processing agents for natural fibers, synthetic fibers, glass fiber, carbon fiber, and metal fibers; building materials, such as sealants, cement admixtures, and waterproof materials; and sealants for electronic/electric devices.
  • EXAMPLES
  • The invention will now be illustrated in greater detail with reference to Preparation Examples and Examples.
  • Preparation Example 1-1 (Preparation of Intermediate A-1)
  • In 40 ml of water was dissolved 1.8 g (20 mmol) of sodium dicyanamide. While stirring at 25°C, 200 g (20 mmol) of a 0.1 M silver nitrate aqueous solution was added thereto dropwise to cause reaction for 2 hours. The precipitate formed was collected by filtration and dried to give 3.3 g of intermediate A-1 (Ag+N(CN)2 -) as pale yellow powder.
  • Preparation Example 1-2 (Preparation of Intermediate A-2)
  • In 40 ml of water was dissolved 1.6 g (20 mmol) of sodium thiocyanate. While stirring at 25°C, 200 g (20 mmol) of a 0.1 M silver nitrate aqueous solution was added thereto dropwise to cause reaction for 2 hours. The precipitate formed was collected by filtration and dried to give 2.3 g of intermediate A-2 (Ag+(SCN)-) as pale yellow powder.
  • Preparation Example 2 (Preparation of Intermediate B)
  • In 55 ml of methanol was dissolved 4.5 g (55 mmol) of 1-methylimidazole. While stirring at 25°C, 5.8 g (55 mmol) of a 35% hydrochloric acid aqueous solution was added thereto dropwise to cause reaction for 1 hour. The solvent was removed on an evaporator, and the residue was dried under reduced pressure to give 6.6 g of intermediate B (a compound represented by the formula below) as pale brown solid.
    Figure imgb0010
  • Preparation Example 3 (Preparation of Intermediate C)
  • In 43 ml of methanol was dissolved 4.7 g (43 mmol) of 2-ethyl-4-methylimidazole. While stirring at 25°C, 4.5 g (43 mmol) of a 35% hydrochloric acid aqueous solution was added thereto dropwise to cause reaction for 1 hour. The solvent was removed on an evaporator, and the residue was dried under reduced pressure to give 5.9 g of intermediate C (a compound represented by the formula below) as pale yellow powder.
    Figure imgb0011
  • Preparation Example 4 (Preparation of Intermediate D
  • In 26 ml of methanol was dissolved 2.6 g (26 mmol) of 1-methyl-1,4,5,6-tetrahydropyrimidine. While stirring at 25°C, 2.7 g (26 mmol) of a 35% hydrochloric acid aqueous solution was added thereto dropwise to cause reaction for 1 hour. The solvent was removed on an evaporator, and the residue was dried under reduced pressure to give 3.7 g of intermediate D (a compound represented by the formula below) as pale yellow powder.
    Figure imgb0012
  • Example 1-1 (Preparation of Curing Agent A-1)
  • In 17 ml of water was dissolved 1.0 g (8.5 mmol) of intermediate B. While stirring at 25°C, 1.5 g (8.5 mmol) of intermediate A-1 was added thereto in divided portions to cause reaction for 24 hours. The solvent was removed on an evaporator, and the residue was dried under reduced pressure to furnish 1.2 g of curing agent A-1 as pale yellow liquid.
  • Example 2-1 (Preparation of Curing Agent B-1)
  • In 20 ml of water was dissolved 1.5 g (10.0 mmol) of intermediate C. While stirring at 25°C, 1.7 g (10.0 mmol) of intermediate A-1 was added thereto in divided portions to cause reaction for 24 hours. The solvent was removed on an evaporator, and the residue was dried under reduced pressure to furnish 1.7 g of curing agent B as pale yellow powder. The resulting curing agent B-1 was identified by 1H-NMR and 13C-NMR. The resulting 1H-NMR and 13C-NMR spectra are shown in Figs. 1 and 2, respectively.
  • Results of identification:
  • 1H-NMR (400 MHz, CD3OD) d: 1.36 (3H, t, J = 7.6 Hz), 2.29 (3H, d, J = 1.0 Hz), 2.92 (2H, q, J = 7.7 Hz), 7.05 (1H, s)
    13C-NMR (100 MHz, CD3OD) d: 8.4, 10.3, 19.0, 114.7, 119.1, 129.1, 148.3
  • Example 3-1 (Preparation of Curing Agent C-1)
  • In 40 ml of water was dissolved 1.2 g (9.2 mmol) of intermediate D. While stirring at 25°C, 1.6 g (9.2 mmol) of intermediate A-1 was added thereto in divided portions to cause reaction for 24 hours. The solvent was removed on an evaporator, and the residue was dried under reduced pressure to afford 1.4 g of curing agent C-1 as pale yellow liquid.
  • Example 4-1 (Preparation of One-pack Type Epoxy Resin Composition A-1)
  • One-pack type epoxy resin composition A-1 was prepared by uniformly mixing 340 g of Adeka Resin EP-4100L from Adeka Corp. (bisphenol A diglycidyl ether epoxy resin; epoxy equivalent: 170 g/eq.; total chlorine content: 600 ppm) with 15 g of curing agent A-1, followed by thoroughly defoaming under reduced pressure at room temperature.
  • Example 5-1 (Preparation of One-pack Type Epoxy Resin Composition B-1)
  • One-pack type epoxy resin composition B-1 was prepared in the same manner as in Example 4, except for using 17.7 g of curing agent B-1.
  • Example 6-1 (Preparation of One-pack Type Epoxy Resin Composition C-1)
  • One-pack type epoxy resin composition C-1 was prepared in the same manner as in Example 4-1, except for using 16.5 g of curing agent C-1.
  • Comparative Example 1 (Preparation of One-pack Type Epoxy Resin Composition D)
  • One-pack type epoxy resin composition D was prepared in the same manner as in Example 4-1, except for using 8.2 g of 1-methylimidazole.
  • Comparative Example 2 (Preparation of One-pack Type Epoxy Resin Composition E)
  • One-pack type epoxy resin composition E was prepared in the same manner as in Example 4-1, except for using 11 g of 2-ethyl-4-methylimidazole.
  • Comparative Example 3 (Preparation of One-pack Type Epoxy Resin Composition F)
  • One-pack type epoxy resin composition D was prepared in the same manner as in Example 4-1, except for using 9.8 g of 1-methyl-1,4,5,6-tetrahydropyrimidine.
  • The one-pack type epoxy resin compositions obtained in Examples and Comparative Examples were evaluated for physical properties in accordance with the following methods.
  • Method of evaluation: (1) One-pack stability test
  • The one-pack type epoxy resin composition was stored hermetically at 40°C immediately after the preparation. The time required for the composition to lose flowability was recorded as a measure for evaluating one-pack stability.
  • (2) Curability
  • The one-pack type epoxy resin composition was caused to gel on a hot plate at 150°C and 180°C. The gelling time was recorded to evaluate curability.
  • Results of evaluation:
  • Table 1
    Example 4-1 Comp. Example 1 Example 5-1 Comp. Example 2 Example 6-1 Comp. Example 3
    One-pack Stability (hr) 48 12 48 6 >200 72
    Gel Time (min) 150°C 1'45" 1'55" 1'10" 1'12" >60 >60
    180°C 0'45" 0'48" 0'30" 0'30" 35 >60
  • As is apparent from the results in Table 1, the use of the nitrogen-containing salt compound having a dicyanamide anion structure as a thermosetting type latent curing agent for epoxy resins provides a one-pack type epoxy resin composition excellent in not only one-pack stability but curability.

Claims (2)

  1. An epoxy resin composition comprising (A) an epoxy resin and (B) at least one of compounds represented by general formulae (1-1), (1-3), (1-4) or (1-5):
    Figure imgb0013
    Figure imgb0014
    wherein R2', R3, R4, R5, R9, R10, R11, R12, R13, R14, and R15 each independently represent a hydrogen atom, an alkyl group, or an aryl group; and X represents a dicyanamide ion.
  2. The epoxy resin composition of claim 1, being a one-pack type thermosetting epoxy resin composition.
EP15745854.8A 2014-02-06 2015-01-22 Novel compound and epoxy resin composition containing same Active EP3103796B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014021055A JP6240940B2 (en) 2014-02-06 2014-02-06 Epoxy resin composition
JP2014076349A JP6300608B2 (en) 2014-04-02 2014-04-02 Novel compound and epoxy resin composition containing the same
PCT/JP2015/051613 WO2015118952A1 (en) 2014-02-06 2015-01-22 Novel compound and epoxy resin composition containing same

Publications (3)

Publication Number Publication Date
EP3103796A1 EP3103796A1 (en) 2016-12-14
EP3103796A4 EP3103796A4 (en) 2017-06-21
EP3103796B1 true EP3103796B1 (en) 2021-08-25

Family

ID=53777759

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15745854.8A Active EP3103796B1 (en) 2014-02-06 2015-01-22 Novel compound and epoxy resin composition containing same

Country Status (6)

Country Link
US (1) US10253136B2 (en)
EP (1) EP3103796B1 (en)
KR (1) KR102311142B1 (en)
CN (1) CN105916844B (en)
TW (1) TWI646086B (en)
WO (1) WO2015118952A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102016223662A1 (en) * 2016-11-29 2018-05-30 Siemens Aktiengesellschaft Potting compound, insulation material and use
CN109525090A (en) * 2017-09-18 2019-03-26 大银微系统股份有限公司 The iron core group of linear motor
CN111704844B (en) * 2020-05-20 2024-03-08 河北省同创交通工程配套产品产业技术研究院 Modified epoxy paint and preparation method and application thereof
CN115557899B (en) * 2022-09-30 2024-03-08 福州大学 Epoxy resin curing accelerator and preparation method thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3642649A (en) 1969-04-18 1972-02-15 Air Prod & Chem Low temperature tertiary amine accelerators
US4761466A (en) * 1987-08-12 1988-08-02 Ashland Oil, Inc. Inidazoline thiocyanates as cure accelerators for amine curing of epoxide resins
DE69133280T2 (en) 1990-05-21 2004-05-06 Dow Global Technologies, Inc., Midland Latent catalysts, curing-inhibited epoxy resin compositions and laminates made therefrom
JP2005032551A (en) * 2003-07-11 2005-02-03 Toshiba Corp Nonaqueous electrolyte secondary battery
WO2008098137A2 (en) * 2007-02-07 2008-08-14 Zettacore, Inc. Liquid composite compositions using non-volatile liquids and nanoparticles and uses thereof
KR101547874B1 (en) 2007-07-26 2015-08-27 아지노모토 가부시키가이샤 Resin composition
EP2067835A1 (en) * 2007-12-07 2009-06-10 Bp Exploration Operating Company Limited Improved aqueous-based wellbore fluids
DE102009000641A1 (en) * 2009-02-05 2010-08-12 Evonik Goldschmidt Gmbh Process for the production of antistatically treated artificial stones for fabrics
CN101950675B (en) * 2010-09-26 2012-06-20 华南理工大学 Dye sensitized solar cell electrolyte based on ionic liquid and preparation method thereof
WO2012042673A1 (en) 2010-10-01 2012-04-05 リケンテクノス株式会社 Two-pack curable epoxy resin coating composition for floor member, and floor member
DE102010043472A1 (en) * 2010-11-05 2012-05-10 Evonik Goldschmidt Gmbh Composition of polymers and electrically conductive carbon
DE202011106028U1 (en) * 2011-08-14 2012-08-17 BLüCHER GMBH New concepts for gas treatment and gas purification
FR2986229B1 (en) * 2012-01-27 2014-03-21 Centre Nat Detudes Spatiales Cnes NEW IONIC MONERGOLS BASED ON N2O FOR SPACE PROPULSION
KR20140002355A (en) 2012-06-29 2014-01-08 삼성전기주식회사 Inductor and process for producing the same
JP6240940B2 (en) 2014-02-06 2017-12-06 株式会社Adeka Epoxy resin composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
EP3103796A1 (en) 2016-12-14
CN105916844A (en) 2016-08-31
KR20160111922A (en) 2016-09-27
WO2015118952A1 (en) 2015-08-13
TW201533030A (en) 2015-09-01
EP3103796A4 (en) 2017-06-21
TWI646086B (en) 2019-01-01
US10253136B2 (en) 2019-04-09
CN105916844B (en) 2018-09-11
KR102311142B1 (en) 2021-10-12
US20160333138A1 (en) 2016-11-17

Similar Documents

Publication Publication Date Title
JP5260639B2 (en) Catalyst for epoxide curing
EP3103796B1 (en) Novel compound and epoxy resin composition containing same
HUT70873A (en) Amine modified epoxide-resin
JP5876414B2 (en) Latent curing agent composition and one-part curable epoxy resin composition
JP4938567B2 (en) One-component cyanate-epoxy composite resin composition
JP6161340B2 (en) Bisimidazole compound, epoxy resin curing agent containing the bisimidazole compound, and one-component curable epoxy resin composition containing the epoxy resin curing agent
KR20100044169A (en) Catalyst for curing epoxides
CA1209297A (en) Heat-curable epoxide resin compositions
CA1185046A (en) Heat-curable epoxide resin compositions
US6258919B1 (en) Curable epoxy resin compositions containing water-processable polyamine hardeners
KR20100044166A (en) Catalyst for curing epoxides
JP6240940B2 (en) Epoxy resin composition
JP5996977B2 (en) Polythiourethane compound, epoxy resin curing agent containing the compound, and one-part curable epoxy resin composition comprising the epoxy resin curing agent
US3635844A (en) Curable molding compositions comprising a polyepoxide and a hydantoin
JP6300608B2 (en) Novel compound and epoxy resin composition containing the same
JPH1059907A (en) Polyamine, its production and lacquer containing the same, coating agent, adhesive agent, resin for impregnation, resin for immersion, and resin for casting
JP2007186547A (en) Curing agent composition for epoxy resin and one-component thermosetting epoxy resin composition
JP6030028B2 (en) Novel compound, thermosetting agent and epoxy resin composition
WO2023074450A1 (en) Clathrate compound, epoxy resin curing agent, and curable resin composition
JPS61268723A (en) Curing agent for epoxy resin
JP6307245B2 (en) Epoxy resin composition
JP2014098070A (en) New compound, and thermosetting agent and epoxy resin composition containing the compound
JP2015034214A (en) One-liquid type curable resin composition
JP2015071753A (en) Curing agent and curable resin composition
JPS60235830A (en) Curable epoxy resin composition

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20160707

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

RIN1 Information on inventor provided before grant (corrected)

Inventor name: OGAWA, RYO

Inventor name: SATO, DAISUKE

Inventor name: ENDO, TAKESHI

Inventor name: MATSUMOTO, KOZO

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20170524

RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 239/06 20060101ALI20170518BHEP

Ipc: C07D 235/06 20060101ALI20170518BHEP

Ipc: C08L 63/00 20060101ALI20170518BHEP

Ipc: C08G 59/40 20060101ALI20170518BHEP

Ipc: C08G 59/50 20060101ALI20170518BHEP

Ipc: C07D 251/14 20060101ALI20170518BHEP

Ipc: C07D 235/08 20060101ALI20170518BHEP

Ipc: C07D 233/58 20060101AFI20170518BHEP

Ipc: C07D 249/08 20060101ALI20170518BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20190607

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20210416

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602015072610

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Ref country code: AT

Ref legal event code: REF

Ref document number: 1423663

Country of ref document: AT

Kind code of ref document: T

Effective date: 20210915

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20210825

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1423663

Country of ref document: AT

Kind code of ref document: T

Effective date: 20210825

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210825

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210825

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211125

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210825

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210825

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211227

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211125

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210825

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210825

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210825

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210825

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210825

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211126

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210825

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210825

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602015072610

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210825

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210825

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210825

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210825

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210825

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210825

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210825

26N No opposition filed

Effective date: 20220527

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210825

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210825

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20220122

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20220131

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220122

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220122

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220131

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220131

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220131

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220131

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220122

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230522

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20150122

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210825

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210825

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20240119

Year of fee payment: 10

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210825